GSK buys exclusive rights from Syndivia for ADC in prostate cancer
GSK PLC on Monday announced an agreement with Syndivia that grants GSK exclusive worldwide rights to develop and commercialise a preclinical antibody-drug conjugate for metastatic...
Mon, 27/10/2025 - 08:52